Overview

A Study to Provide Continued Access to Mitapivat for Participants Who Previously Completed an Agios-Sponsored Mitapivat Study

Status:
Not yet recruiting
Trial end date:
2029-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to provide continued access to mitapivat for participants who completed an Agios-sponsored mitapivat study (antecedent) and do not have commercial access to mitapivat.
Phase:
Phase 4
Details
Lead Sponsor:
Agios Pharmaceuticals, Inc.